SeaCrest Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16,100	Closed	-$334K	–	2122
2018 Q3	$334K	Buy	+16,100	New	+$334K	0.06%	365
2018 Q2	–	Sell	-500	Closed	-$11K	–	2186
2018 Q1	$11K	Sell	500 -700	-58%	-$15.4K	﹤0.01%	1534
2017 Q4	$36K	Buy	+1,200	New	+$36K	0.01%	1093